You are here

  • Home
  • Archive
  • Volume 11, Issue 1
  • New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors

Article metrics

Article menu
Immunotherapy biomarkers
Original research
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors

 

Online download statistics by month:

Online download statistics by month: January 2023 to June 2025

AbstractFullPdf
Jan 2023601607182
Feb 202319519774
Mar 202313013051
Apr 202313713847
May 2023999927
Jun 202312012029
Jul 202313213243
Aug 202317217138
Sep 202312112243
Oct 202311411839
Nov 202313313453
Dec 2023909135
Jan 2024616135
Feb 202410710940
Mar 202414414682
Apr 202411011348
May 202420220752
Jun 202412512442
Jul 202414815166
Aug 20241019835
Sep 2024969925
Oct 202413414634
Nov 202410610939
Dec 202411511734
Jan 202510811347
Feb 202514014040
Mar 2025727226
Apr 202510210332
May 2025899041
Jun 2025686825
Total407241251404